{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T07:23:57Z","timestamp":1792567437512,"version":"4.5.0"},"reference-count":165,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.maturitas.2023.107854","type":"journal-article","created":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T20:57:40Z","timestamp":1697317060000},"page":"107854","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["EMAS position statement: Testosterone replacement therapy in older men"],"prefix":"10.1016","volume":"178","author":[{"given":"George A.","family":"Kanakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Pofi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios G.","family":"Goulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9037-5417","authenticated-orcid":false,"given":"Andrea M.","family":"Isidori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Armeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Tamer","family":"Erel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Fistoni\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Hillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelica-Lind\u00e9n","family":"Hirschberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blazej","family":"Meczekalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00e1s","family":"Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred O.","family":"Mueck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Simoncini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Stute","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorenda","family":"van Dijken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Rees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Lambrinoudaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.maturitas.2023.107854_bb0010","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1210\/jc.2007-1972","article-title":"Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study","volume":"93","author":"Wu","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"10.1016\/j.maturitas.2023.107854_bb0015","doi-asserted-by":"crossref","first-page":"5920","DOI":"10.1210\/jc.2003-031719","article-title":"Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study","volume":"89","author":"Araujo","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.maturitas.2023.107854_bb0020","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa0911101","article-title":"Identification of late-onset hypogonadism in middle-aged and elderly men","volume":"363","author":"Wu","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.maturitas.2023.107854_bb0025","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.jsxm.2018.06.012","article-title":"Endogenous testosterone levels and cardiovascular risk: meta-analysis of observational studies","volume":"15","author":"Corona","year":"2018","journal-title":"J. Sex. Med."},{"issue":"6","key":"10.1016\/j.maturitas.2023.107854_bb0030","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1111\/andr.12876","article-title":"Late-onset hypogonadism: reductio ad absurdum of the cardiovascular risk-benefit of testosterone replacement therapy","volume":"8","author":"Sesti","year":"2020","journal-title":"Andrology."},{"issue":"7","key":"10.1016\/j.maturitas.2023.107854_bb0035","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/nrendo.2013.73","article-title":"Risks and benefits of testosterone therapy in older men","volume":"9","author":"Spitzer","year":"2013","journal-title":"Nat. Rev. Endocrinol."},{"issue":"7","key":"10.1016\/j.maturitas.2023.107854_bb0040","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1056\/NEJMoa1506119","article-title":"Effects of testosterone treatment in older men","volume":"374","author":"Snyder","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.maturitas.2023.107854_bb0045","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.maturitas.2015.11.003","article-title":"EMAS position statement: testosterone replacement therapy in the aging male","volume":"84","author":"Dimopoulou","year":"2016","journal-title":"Maturitas."},{"issue":"3","key":"10.1016\/j.maturitas.2023.107854_bb0050","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1210\/jc.2016-3580","article-title":"A perspective on middle-aged and older men with functional hypogonadism: focus on holistic management","volume":"102","author":"Grossmann","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.maturitas.2023.107854_bb0055","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1517\/14728214.2012.683411","article-title":"Emerging medication for the treatment of male hypogonadism","volume":"17","author":"Corona","year":"2012","journal-title":"Expert Opin. Emerg. Drugs"},{"issue":"12","key":"10.1016\/j.maturitas.2023.107854_bb0060","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.jsxm.2016.10.009","article-title":"Diagnosis and treatment of testosterone deficiency: recommendations from the fourth international consultation for sexual medicine (ICSM 2015)","volume":"13","author":"Khera","year":"2016","journal-title":"J. Sex. Med."},{"issue":"3","key":"10.1016\/j.maturitas.2023.107854_bb0065","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1517\/14656566.2015.993607","article-title":"The pharmacotherapy of male hypogonadism besides androgens","volume":"16","author":"Corona","year":"2015","journal-title":"Expert. Opin. Pharmacother."},{"issue":"6","key":"10.1016\/j.maturitas.2023.107854_bb0070","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.jsxm.2018.04.641","article-title":"Testosterone and cardiovascular risk: meta-analysis of interventional studies","volume":"15","author":"Corona","year":"2018","journal-title":"J. Sex. Med."},{"key":"10.1016\/j.maturitas.2023.107854_bb0075","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1146\/annurev-med-050219-034711","article-title":"Benefits and risks of testosterone treatment in men with age-related decline in testosterone","volume":"72","author":"Rodrigues Dos Santos","year":"2021","journal-title":"Annu. Rev. Med."},{"issue":"6","key":"10.1016\/j.maturitas.2023.107854_bb0080","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1111\/andr.12774","article-title":"Testosterone replacement therapy","volume":"8","author":"Barbonetti","year":"2020","journal-title":"Andrology."},{"issue":"13","key":"10.1016\/j.maturitas.2023.107854_bb0085","doi-asserted-by":"crossref","first-page":"E321","DOI":"10.1503\/cmaj.150262","article-title":"Predicting low testosterone in aging men: a systematic review","volume":"188","author":"Millar","year":"2016","journal-title":"CMAJ."},{"issue":"6","key":"10.1016\/j.maturitas.2023.107854_bb0090","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/andr.274","article-title":"Systematic literature review of the risk factors, comorbidities, and consequences of hypogonadism in men","volume":"2","author":"Zarotsky","year":"2014","journal-title":"Andrology."},{"key":"10.1016\/j.maturitas.2023.107854_bb0095","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.maturitas.2019.04.203","article-title":"Measuring testosterone in women and men","volume":"125","author":"Kanakis","year":"2019","journal-title":"Maturitas."},{"issue":"4","key":"10.1016\/j.maturitas.2023.107854_bb0100","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1210\/jc.2016-2935","article-title":"Harmonized reference ranges for circulating testosterone levels in men of four cohort studies in the United States and Europe","volume":"102","author":"Travison","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.maturitas.2023.107854_bb0105","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1210\/jc.2017-02360","article-title":"Reassessing free-testosterone calculation by liquid chromatography-tandem mass spectrometry direct equilibrium dialysis","volume":"103","author":"Fiers","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.maturitas.2023.107854_bb0110","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jsbmb.2019.04.008","article-title":"Assessment of free testosterone concentration","volume":"190","author":"Keevil","year":"2019","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"2","key":"10.1016\/j.maturitas.2023.107854_bb0115","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1210\/jc.2006-1864","article-title":"Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement","volume":"92","author":"Rosner","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.maturitas.2023.107854_bb0120","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1373\/clinchem.2005.063354","article-title":"Calculation of bioavailable and free testosterone in men: a comparison of 5 published algorithms","volume":"52","author":"de Ronde","year":"2006","journal-title":"Clin. Chem."},{"issue":"6","key":"10.1016\/j.maturitas.2023.107854_bb0125","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1046\/j.1365-2265.2003.01772.x","article-title":"Diurnal rhythms of serum total, free and bioavailable testosterone and of SHBG in middle-aged men compared with those in young men","volume":"58","author":"Diver","year":"2003","journal-title":"Clin. Endocrinol."},{"issue":"6","key":"10.1016\/j.maturitas.2023.107854_bb0130","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1439-0272.2012.01296.x","article-title":"S-testosterone decrease after a mixed meal in healthy men independent of SHBG and gonadotrophin levels","volume":"44","author":"Lehtihet","year":"2012","journal-title":"Andrologia."},{"issue":"6","key":"10.1016\/j.maturitas.2023.107854_bb0135","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1365-2265.2007.02976.x","article-title":"Intraindividual variation in levels of serum testosterone and other reproductive and adrenal hormones in men","volume":"67","author":"Brambilla","year":"2007","journal-title":"Clin. Endocrinol."},{"issue":"4","key":"10.1016\/j.maturitas.2023.107854_bb0140","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/ajhb.21045","article-title":"Toward quantifying the usage costs of human immunity: altered metabolic rates and hormone levels during acute immune activation in men","volume":"22","author":"Muehlenbein","year":"2010","journal-title":"Am. J. Hum. Biol."},{"issue":"7","key":"10.1016\/j.maturitas.2023.107854_bb0145","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.jsxm.2016.04.068","article-title":"Challenges in testosterone measurement, data interpretation, and methodological appraisal of interventional trials","volume":"13","author":"Trost","year":"2016","journal-title":"J. Sex. Med."},{"issue":"8","key":"10.1016\/j.maturitas.2023.107854_bb0150","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1210\/jc.2010-3012","article-title":"Reference ranges for testosterone in men generated using liquid chromatography tandem mass spectrometry in a community-based sample of healthy nonobese young men in the Framingham Heart Study and applied to three geographically distinct cohorts","volume":"96","author":"Bhasin","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.maturitas.2023.107854_bb0155","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.eururo.2017.03.032","article-title":"Meta-analysis of results of testosterone therapy on sexual function based on international index of erectile function scores","volume":"72","author":"Corona","year":"2017","journal-title":"Eur. Urol."},{"issue":"5","key":"10.1016\/j.maturitas.2023.107854_bb0160","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1111\/j.1743-6109.2007.00569.x","article-title":"Effect of hyperprolactinemia in male patients consulting for sexual dysfunction","volume":"4","author":"Corona","year":"2007","journal-title":"J. Sex. Med."},{"issue":"9","key":"10.1016\/j.maturitas.2023.107854_bb0165","doi-asserted-by":"crossref","first-page":"926","DOI":"10.4158\/EP-2018-0609","article-title":"Pituitary imaging by MRI and its correlation with biochemical parameters in the evaluation of men with hypogonadotropic hypogonadism","volume":"25","author":"Das","year":"2019","journal-title":"Endocr. Pract."},{"issue":"8","key":"10.1016\/j.maturitas.2023.107854_bb0170","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11934-018-0808-x","article-title":"Iron and a man\u2019s reproductive health: the good, the bad, and the ugly","volume":"19","author":"Gabrielsen","year":"2018","journal-title":"Curr. Urol. Rep."},{"issue":"3","key":"10.1016\/j.maturitas.2023.107854_bb0175","doi-asserted-by":"crossref","first-page":"D1","DOI":"10.1530\/EJE-21-0362","article-title":"Functional hypogonadism in middle-aged and older men: testosterone treatment or not?","volume":"185","author":"Grossmann","year":"2021","journal-title":"Eur. J. Endocrinol."},{"issue":"4","key":"10.1016\/j.maturitas.2023.107854_bb0180","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.beem.2011.12.005","article-title":"Subclinical male hypogonadism","volume":"26","author":"Giannetta","year":"2012","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"12","key":"10.1016\/j.maturitas.2023.107854_bb0185","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1007\/s40618-022-01859-7","article-title":"Adult- and late-onset male hypogonadism: the clinical practice guidelines of the Italian Society of Andrology and Sexual Medicine (SIAMS) and the Italian Society of Endocrinology (SIE)","volume":"45","author":"Isidori","year":"2022","journal-title":"J. Endocrinol. Investig."},{"issue":"2","key":"10.1016\/j.maturitas.2023.107854_bb0190","doi-asserted-by":"crossref","first-page":"105","DOI":"10.7326\/M19-0830","article-title":"Efficacy and safety of testosterone treatment in men: an evidence report for a clinical practice guideline by the American College of Physicians","volume":"172","author":"Diem","year":"2020","journal-title":"Ann. Intern. Med."},{"issue":"6","key":"10.1016\/j.maturitas.2023.107854_bb0195","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/jsm.12536","article-title":"Testosterone supplementation and sexual function: a meta-analysis study","volume":"11","author":"Corona","year":"2014","journal-title":"J. Sex. Med."},{"issue":"11","key":"10.1016\/j.maturitas.2023.107854_bb0200","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-015284","article-title":"Testosterone therapy in hypogonadal men: a systematic review and network meta-analysis","volume":"7","author":"Elliott","year":"2017","journal-title":"BMJ Open"},{"issue":"5","key":"10.1016\/j.maturitas.2023.107854_bb0205","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1210\/jc.2018-00404","article-title":"The efficacy and adverse events of testosterone replacement therapy in hypogonadal men: a systematic review and meta-analysis of randomized, placebo-controlled trials","volume":"103","author":"Ponce","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.maturitas.2023.107854_bb0210","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.jsxm.2017.07.004","article-title":"Quality of life and sexual function benefits of long-term testosterone treatment: longitudinal results from the Registry of Hypogonadism in Men (RHYME)","volume":"14","author":"Rosen","year":"2017","journal-title":"J. Sex. Med."},{"issue":"5","key":"10.1016\/j.maturitas.2023.107854_bb0215","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.eururo.2011.07.053","article-title":"Minimal clinically important differences in the erectile function domain of the International Index of Erectile Function scale","volume":"60","author":"Rosen","year":"2011","journal-title":"Eur. Urol."},{"issue":"9","key":"10.1016\/j.maturitas.2023.107854_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162480","article-title":"Treatment of men for \u201clow testosterone\u201d: a systematic review","volume":"11","author":"Huo","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.maturitas.2023.107854_bb0225","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.eururo.2013.08.048","article-title":"A critical analysis of the role of testosterone in erectile function: from pathophysiology to treatment-a systematic review","volume":"65","author":"Isidori","year":"2014","journal-title":"Eur. Urol."},{"issue":"8","key":"10.1016\/j.maturitas.2023.107854_bb0230","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1210\/jc.2014-4434","article-title":"Testosterone replacement in androgen-deficient men with ejaculatory dysfunction: a randomized controlled trial","volume":"100","author":"Paduch","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.maturitas.2023.107854_bb0235","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3109\/13685538.2013.879113","article-title":"Testosterone and type 2 diabetes in men","volume":"17","author":"Mazur","year":"2014","journal-title":"Aging Male"},{"issue":"2","key":"10.1016\/j.maturitas.2023.107854_bb0240","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1210\/jc.2006-1859","article-title":"The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men","volume":"92","author":"Travison","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.maturitas.2023.107854_bb0245","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/13685538.2018.1506918","article-title":"Influence of testosterone substitution on glycemic control and endothelial markers in men with newly diagnosed functional hypogonadism and type 2 diabetes mellitus: a randomized controlled trial","volume":"22","author":"Khripun","year":"2019","journal-title":"Aging Male"},{"issue":"8","key":"10.1016\/j.maturitas.2023.107854_bb0250","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00592-018-1163-6","article-title":"The role of sex hormone-binding globulin (SHBG), testosterone, and other sex steroids, on the development of type 2 diabetes in a cohort of community-dwelling middle-aged to elderly men","volume":"55","author":"Gyawali","year":"2018","journal-title":"Acta Diabetol."},{"issue":"1","key":"10.1016\/j.maturitas.2023.107854_bb0255","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12902-016-0109-7","article-title":"Predictive value of serum testosterone for type 2 diabetes risk assessment in men","volume":"16","author":"Atlantis","year":"2016","journal-title":"BMC Endocr. Disord."},{"issue":"11","key":"10.1016\/j.maturitas.2023.107854_bb0260","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1001\/jama.295.11.1288","article-title":"Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis","volume":"295","author":"Ding","year":"2006","journal-title":"JAMA."},{"issue":"1","key":"10.1016\/j.maturitas.2023.107854_bb0265","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S2213-8587(20)30367-3","article-title":"Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial","volume":"9","author":"Wittert","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"5","key":"10.1016\/j.maturitas.2023.107854_bb0270","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/MED.0000000000000086","article-title":"Testosterone and weight loss: the evidence","volume":"21","author":"Traish","year":"2014","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"issue":"11","key":"10.1016\/j.maturitas.2023.107854_bb0275","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1111\/dom.14122","article-title":"Remission of type 2 diabetes following long-term treatment with injectable testosterone undecanoate in patients with hypogonadism and type 2 diabetes: 11-year data from a real-world registry study","volume":"22","author":"Haider","year":"2020","journal-title":"Diabetes Obes. Metab."},{"issue":"6","key":"10.1016\/j.maturitas.2023.107854_bb0280","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.2337\/dc18-2388","article-title":"Testosterone therapy in men with hypogonadism prevents progression from prediabetes to type 2 diabetes: eight-year data from a registry study","volume":"42","author":"Yassin","year":"2019","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.maturitas.2023.107854_bb0285","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.2337\/dc13-2845","article-title":"Effect of testosterone treatment on glucose metabolism in men with type 2 diabetes: a randomized controlled trial","volume":"37","author":"Gianatti","year":"2014","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.maturitas.2023.107854_bb0290","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1080\/13685538.2018.1468429","article-title":"The impact of testosterone replacement therapy on glycemic control, vascular function, and components of the metabolic syndrome in obese hypogonadal men with type 2 diabetes","volume":"21","author":"Groti","year":"2018","journal-title":"Aging Male"},{"issue":"1","key":"10.1016\/j.maturitas.2023.107854_bb0295","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2337\/dc15-1518","article-title":"Insulin resistance and inflammation in hypogonadotropic hypogonadism and their reduction after testosterone replacement in men with type 2 diabetes","volume":"39","author":"Dhindsa","year":"2016","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.maturitas.2023.107854_bb0300","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1007\/s11255-021-02876-w","article-title":"Efficacy of testosterone replacement therapy for treating metabolic disturbances in late-onset hypogonadism: a systematic review and meta-analysis","volume":"53","author":"Kim","year":"2021","journal-title":"Int. Urol. Nephrol."},{"issue":"8","key":"10.1016\/j.maturitas.2023.107854_bb0305","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s00345-018-2256-0","article-title":"Effects of testosterone supplement treatment in hypogonadal adult males with T2DM: a meta-analysis and systematic review","volume":"36","author":"Zhang","year":"2018","journal-title":"World J. Urol."},{"issue":"1","key":"10.1016\/j.maturitas.2023.107854_bb0310","doi-asserted-by":"crossref","first-page":"146","DOI":"10.4103\/1008-682X.122346","article-title":"Metabolic effects of testosterone replacement therapy on hypogonadal men with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials","volume":"16","author":"Cai","year":"2014","journal-title":"Asian J. Androl."},{"issue":"3","key":"10.1016\/j.maturitas.2023.107854_bb0315","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/cen.12664","article-title":"Effects of testosterone treatment on glucose metabolism and symptoms in men with type 2 diabetes and the metabolic syndrome: a systematic review and meta-analysis of randomized controlled clinical trials","volume":"83","author":"Grossmann","year":"2015","journal-title":"Clin. Endocrinol."},{"issue":"1","key":"10.1016\/j.maturitas.2023.107854_bb0320","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/andr.12425","article-title":"Effects of testosterone supplementation therapy on lipid metabolism in hypogonadal men with T2DM: a meta-analysis of randomized controlled trials","volume":"6","author":"Zhang","year":"2018","journal-title":"Andrology."},{"issue":"9","key":"10.1016\/j.maturitas.2023.107854_bb0325","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s40618-016-0480-2","article-title":"Testosterone supplementation and body composition: results from a meta-analysis of observational studies","volume":"39","author":"Corona","year":"2016","journal-title":"J. Endocrinol. Investig."},{"issue":"1","key":"10.1016\/j.maturitas.2023.107854_bb0330","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12916-016-0700-9","article-title":"Effects of testosterone treatment on body fat and lean mass in obese men on a hypocaloric diet: a randomised controlled trial","volume":"14","author":"Ng Tang Fui","year":"2016","journal-title":"BMC Med."},{"issue":"3","key":"10.1016\/j.maturitas.2023.107854_bb0335","doi-asserted-by":"crossref","first-page":"e1096","DOI":"10.1210\/clinem\/dgaa917","article-title":"Testosterone replacement therapy added to intensive lifestyle intervention in older men with obesity and hypogonadism","volume":"106","author":"Barnouin","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.maturitas.2023.107854_bb0340","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/cen.13385","article-title":"The effects of testosterone on body composition in obese men are not sustained after cessation of testosterone treatment","volume":"87","author":"Ng Tang Fui","year":"2017","journal-title":"Clin. Endocrinol."},{"issue":"1","key":"10.1016\/j.maturitas.2023.107854_bb0345","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1530\/EJE-21-0473","article-title":"Effectiveness of testosterone replacement in men with obesity: a systematic review and meta-analysis","volume":"186","author":"Mangolim","year":"2021","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"10.1016\/j.maturitas.2023.107854_bb0350","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1152\/physrev.00033.2015","article-title":"Estrogens and androgens in skeletal physiology and pathophysiology","volume":"97","author":"Almeida","year":"2017","journal-title":"Physiol. Rev."},{"issue":"6","key":"10.1016\/j.maturitas.2023.107854_bb0355","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1111\/andr.12827","article-title":"Late-onset hypogonadism: bone health","volume":"8","author":"Rochira","year":"2020","journal-title":"Andrology."},{"issue":"9","key":"10.1016\/j.maturitas.2023.107854_bb0360","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nrendo.2013.135","article-title":"Testicular function and bone metabolism\u2014beyond testosterone","volume":"9","author":"Ferlin","year":"2013","journal-title":"Nat. Rev. Endocrinol."},{"issue":"2","key":"10.1016\/j.maturitas.2023.107854_bb0365","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/andr.12470","article-title":"EAA clinical guideline on management of bone health in the andrological outpatient clinic","volume":"6","author":"Rochira","year":"2018","journal-title":"Andrology."},{"issue":"3","key":"10.1016\/j.maturitas.2023.107854_bb0370","doi-asserted-by":"crossref","first-page":"R75","DOI":"10.1530\/EJE-20-0034","article-title":"Management of endocrine disease: male osteoporosis: diagnosis and management - should the treatment and the target be the same as for female osteoporosis?","volume":"183","author":"Porcelli","year":"2020","journal-title":"Eur. J. Endocrinol."},{"issue":"5","key":"10.1016\/j.maturitas.2023.107854_bb0375","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1210\/jc.2018-00229","article-title":"Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline","volume":"103","author":"Bhasin","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.maturitas.2023.107854_bb0380","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/andr.12770","article-title":"European Academy of Andrology (EAA) guidelines on investigation, treatment and monitoring of functional hypogonadism in males: endorsing organization: European Society of Endocrinology","volume":"8","author":"Corona","year":"2020","journal-title":"Andrology."},{"issue":"2","key":"10.1016\/j.maturitas.2023.107854_bb0385","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3109\/13685538.2011.631230","article-title":"Effects of long-acting testosterone undecanoate on bone mineral density in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 36 months controlled study","volume":"15","author":"Aversa","year":"2012","journal-title":"Aging Male"},{"issue":"3","key":"10.1016\/j.maturitas.2023.107854_bb0390","first-page":"139","article-title":"Effects of testosterone replacement therapy on hypogonadal men with osteopenia or osteoporosis: a subanalysis of a prospective randomized controlled study in Japan (EARTH study)","volume":"20","author":"Shigehara","year":"2017","journal-title":"Aging Male"},{"issue":"1","key":"10.1016\/j.maturitas.2023.107854_bb0395","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12902-020-0509-6","article-title":"The effects of testosterone on bone health in males with testosterone deficiency: a systematic review and meta-analysis","volume":"20","author":"Zhang","year":"2020","journal-title":"BMC Endocr. Disord."},{"issue":"5","key":"10.1016\/j.maturitas.2023.107854_bb0400","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s40618-021-01702-5","article-title":"Testosterone supplementation and bone parameters: a systematic review and meta-analysis study","volume":"45","author":"Corona","year":"2022","journal-title":"J. Endocrinol. Investig."},{"issue":"8","key":"10.1016\/j.maturitas.2023.107854_bb0405","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1002\/jbmr.81","article-title":"Microarchitectural deterioration of cortical and trabecular bone: differing effects of denosumab and alendronate","volume":"25","author":"Seeman","year":"2010","journal-title":"J. Bone Miner. Res."},{"issue":"12","key":"10.1016\/j.maturitas.2023.107854_bb0410","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1002\/jbmr.157","article-title":"A longitudinal HR-pQCT study of alendronate treatment in postmenopausal women with low bone density: relations among density, cortical and trabecular microarchitecture, biomechanics, and bone turnover","volume":"25","author":"Burghardt","year":"2010","journal-title":"J. Bone Miner. Res."},{"issue":"4","key":"10.1016\/j.maturitas.2023.107854_bb0415","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/jbmr.1784","article-title":"Differing effects of PTH 1-34, PTH 1-84, and zoledronic acid on bone microarchitecture and estimated strength in postmenopausal women with osteoporosis: an 18-month open-labeled observational study using HR-pQCT","volume":"28","author":"Hansen","year":"2013","journal-title":"J. Bone Miner. Res."},{"issue":"7","key":"10.1016\/j.maturitas.2023.107854_bb0420","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1002\/jbmr.4566","article-title":"Safety and efficacy of PTH 1-34 and 1-84 therapy in chronic hypoparathyroidism: a meta-analysis of prospective trials","volume":"37","author":"Puliani","year":"2022","journal-title":"J. Bone Miner. Res."},{"issue":"8","key":"10.1016\/j.maturitas.2023.107854_bb0425","doi-asserted-by":"crossref","first-page":"e3058","DOI":"10.1210\/clinem\/dgab181","article-title":"Testosterone therapy effects on bone mass and turnover in hypogonadal men with type 2 diabetes","volume":"106","author":"Colleluori","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.maturitas.2023.107854_bb0430","doi-asserted-by":"crossref","first-page":"e3143","DOI":"10.1210\/clinem\/dgab149","article-title":"Effect of testosterone treatment on bone microarchitecture and bone mineral density in men: a 2-year RCT","volume":"106","author":"Ng Tang Fui","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.maturitas.2023.107854_bb0435","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/jamainternmed.2016.9539","article-title":"Effect of testosterone treatment on volumetric bone density and strength in older men with low testosterone: a controlled clinical trial","volume":"177","author":"Snyder","year":"2017","journal-title":"JAMA Intern. Med."},{"issue":"4","key":"10.1016\/j.maturitas.2023.107854_bb0440","doi-asserted-by":"crossref","DOI":"10.1111\/and.12630","article-title":"Testosterone replacement therapy improves health-related quality of life for patients with late-onset hypogonadism: a meta-analysis of randomized controlled trials","volume":"49","author":"Nian","year":"2017","journal-title":"Andrologia."},{"issue":"6","key":"10.1016\/j.maturitas.2023.107854_bb0445","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.psym.2013.06.018","article-title":"The effect of testosterone levels on mood in men: a review","volume":"54","author":"Johnson","year":"2013","journal-title":"Psychosomatics."},{"issue":"1","key":"10.1016\/j.maturitas.2023.107854_bb0450","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/104012371402600103","article-title":"Impact of exogenous testosterone on mood: a systematic review and meta-analysis of randomized placebo-controlled trials","volume":"26","author":"Amanatkar","year":"2014","journal-title":"Ann. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.maturitas.2023.107854_bb0455","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.euf.2018.07.006","article-title":"Systematic review of the impact of testosterone replacement therapy on depression in patients with late-onset testosterone deficiency","volume":"6","author":"Vartolomei","year":"2020","journal-title":"Eur. Urol. Focus"},{"issue":"1","key":"10.1016\/j.maturitas.2023.107854_bb0460","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/jamapsychiatry.2018.2734","article-title":"Association of testosterone treatment with alleviation of depressive symptoms in men: a systematic review and meta-analysis","volume":"76","author":"Walther","year":"2019","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.maturitas.2023.107854_bb0465","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199607043350101","article-title":"The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men","volume":"335","author":"Bhasin","year":"1996","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.maturitas.2023.107854_bb0470","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1210\/jc.2017-01902","article-title":"Long-term testosterone supplementation in older men attenuates age-related decline in aerobic capacity","volume":"103","author":"Traustadottir","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.maturitas.2023.107854_bb0475","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/andr.12169","article-title":"Cross-sectional association between physical activity and serum testosterone levels in US men: results from NHANES 1999-2004","volume":"4","author":"Steeves","year":"2016","journal-title":"Andrology."},{"issue":"2","key":"10.1016\/j.maturitas.2023.107854_bb0480","first-page":"127","article-title":"Neuroprotection of sex steroids","volume":"35","author":"Liu","year":"2010","journal-title":"Minerva Endocrinol."},{"issue":"8","key":"10.1016\/j.maturitas.2023.107854_bb0485","first-page":"2271","article-title":"Cognitive functioning in men receiving androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis","volume":"22","author":"McGinty","year":"2014","journal-title":"Support Care Cancer"},{"issue":"7","key":"10.1016\/j.maturitas.2023.107854_bb0490","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1001\/jama.2016.21044","article-title":"Testosterone treatment and cognitive function in older men with low testosterone and age-associated memory impairment","volume":"317","author":"Resnick","year":"2017","journal-title":"JAMA."},{"issue":"1","key":"10.1016\/j.maturitas.2023.107854_bb0495","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5534\/wjmh.200017","article-title":"Testosterone deficiency and risk of cognitive disorders in aging males","volume":"39","author":"Corona","year":"2021","journal-title":"World J0 Mens Health"},{"issue":"11","key":"10.1016\/j.maturitas.2023.107854_bb0500","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.jagp.2019.05.008","article-title":"Effects of testosterone supplementation on separate cognitive domains in cognitively healthy older men: a meta-analysis of current randomized clinical trials","volume":"27","author":"Tan","year":"2019","journal-title":"Am. J. Geriatr. Psychiatry"},{"issue":"8","key":"10.1016\/j.maturitas.2023.107854_bb0505","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1210\/js.2019-00119","article-title":"Testosterone supplementation and cognitive functioning in men-a systematic review and meta-analysis","volume":"3","author":"Buskbjerg","year":"2019","journal-title":"J. Endocr. Soc."},{"issue":"8","key":"10.1016\/j.maturitas.2023.107854_bb0510","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1210\/clinem\/dgaa238","article-title":"A new oral testosterone undecanoate formulation restores testosterone to normal concentrations in hypogonadal men","volume":"105","author":"Swerdloff","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"24","key":"10.1016\/j.maturitas.2023.107854_bb0515","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1056\/NEJMra1707939","article-title":"Breast cancer in men","volume":"378","author":"Giordano","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.maturitas.2023.107854_bb0520","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/BF03347072","article-title":"Androgen regulation of prostate cancer: where are we now?","volume":"34","author":"Corona","year":"2011","journal-title":"J. Endocrinol. Investig."},{"issue":"11","key":"10.1016\/j.maturitas.2023.107854_bb0525","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1093\/gerona\/60.11.1451","article-title":"Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials","volume":"60","author":"Calof","year":"2005","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"3","key":"10.1016\/j.maturitas.2023.107854_bb0530","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1080\/2090598X.2021.1959260","article-title":"A systematic review on the latest developments in testosterone therapy: innovations, advances, and paradigm shifts","volume":"19","author":"Al-Zoubi","year":"2021","journal-title":"Arab. J. Urol."},{"issue":"11","key":"10.1016\/j.maturitas.2023.107854_bb0535","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1210\/clinem\/dgaa521","article-title":"Markers of Iron flux during testosterone-mediated erythropoiesis in older men with unexplained or Iron-deficiency anemia","volume":"105","author":"Artz","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.maturitas.2023.107854_bb0540","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2143\/AC.57.3.2005387","article-title":"Red blood cell count in short-term prediction of cardiovascular disease incidence in the Gubbio population study","volume":"57","author":"Puddu","year":"2002","journal-title":"Acta Cardiol."},{"issue":"2","key":"10.1016\/j.maturitas.2023.107854_bb0545","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa2215025","article-title":"Cardiovascular safety of testosterone-replacement therapy","volume":"389","author":"Lincoff","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.maturitas.2023.107854_bb0550","doi-asserted-by":"crossref","first-page":"l476","DOI":"10.1136\/bmj.l476","article-title":"Association of genetically predicted testosterone with thromboembolism, heart failure, and myocardial infarction: mendelian randomisation study in UK Biobank","volume":"364","author":"Luo","year":"2019","journal-title":"BMJ."},{"issue":"10","key":"10.1016\/j.maturitas.2023.107854_bb0555","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1111\/jth.12678","article-title":"Differential risks in men and women for first and recurrent venous thrombosis: the role of genes and environment","volume":"12","author":"Roach","year":"2014","journal-title":"J. Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.maturitas.2023.107854_bb0560","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1530\/EJE-08-0888","article-title":"Endogenous sex hormone levels in men are not associated with risk of venous thromboembolism: the Tromso study","volume":"160","author":"Svartberg","year":"2009","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.maturitas.2023.107854_bb0565","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1741-7015-11-57","article-title":"The effect of statins on testosterone in men and women, a systematic review and meta-analysis of randomized controlled trials","volume":"11","author":"Schooling","year":"2013","journal-title":"BMC Med."},{"key":"10.1016\/j.maturitas.2023.107854_bb0570","doi-asserted-by":"crossref","first-page":"i5968","DOI":"10.1136\/bmj.i5968","article-title":"Testosterone treatment and risk of venous thromboembolism: population based case-control study","volume":"355","author":"Martinez","year":"2016","journal-title":"BMJ."},{"key":"10.1016\/j.maturitas.2023.107854_bb0575","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12878-016-0045-9","article-title":"Hospitalization for pulmonary embolism associated with antecedent testosterone or estrogen therapy in patients found to have familial and acquired thrombophilia","volume":"16","author":"Prince","year":"2016","journal-title":"BMC Hematol."},{"issue":"5","key":"10.1016\/j.maturitas.2023.107854_bb0580","doi-asserted-by":"crossref","first-page":"101627","DOI":"10.1016\/j.beem.2022.101627","article-title":"Androgens in male contraception","volume":"36","author":"Thirumalai","year":"2022","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.maturitas.2023.107854_bb0585","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1093\/humrep\/deh834","article-title":"Rates of suppression and recovery of human sperm output in testosterone-based hormonal contraceptive regimens","volume":"20","author":"Ly","year":"2005","journal-title":"Hum. Reprod."},{"issue":"2","key":"10.1016\/j.maturitas.2023.107854_bb0590","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.mayocp.2014.10.011","article-title":"Testosterone therapy and cardiovascular risk: advances and controversies","volume":"90","author":"Morgentaler","year":"2015","journal-title":"Mayo Clin. Proc."},{"issue":"6","key":"10.1016\/j.maturitas.2023.107854_bb0595","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S2213-8587(16)00112-1","article-title":"Survival and cardiovascular events in men treated with testosterone replacement therapy: an intention-to-treat observational cohort study","volume":"4","author":"Wallis","year":"2016","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"17","key":"10.1016\/j.maturitas.2023.107854_bb0600","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1001\/jama.2013.280386","article-title":"Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels","volume":"310","author":"Vigen","year":"2013","journal-title":"JAMA."},{"issue":"1","key":"10.1016\/j.maturitas.2023.107854_bb0605","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085805","article-title":"Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men","volume":"9","author":"Finkle","year":"2014","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.maturitas.2023.107854_bb0610","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.4158\/EP14434.PS","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology position statement on the association of testosterone and cardiovascular risk","volume":"21","author":"Goodman","year":"2015","journal-title":"Endocr. Pract."},{"issue":"2","key":"10.1016\/j.maturitas.2023.107854_bb0615","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa1000485","article-title":"Adverse events associated with testosterone administration","volume":"363","author":"Basaria","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.maturitas.2023.107854_bb0620","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/1741-7015-11-108","article-title":"Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials","volume":"11","author":"Xu","year":"2013","journal-title":"BMC Med."},{"issue":"9","key":"10.1016\/j.maturitas.2023.107854_bb0625","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jama.2014.392","article-title":"Deaths and cardiovascular events in men receiving testosterone","volume":"311","author":"Morgentaler","year":"2014","journal-title":"JAMA."},{"issue":"3","key":"10.1016\/j.maturitas.2023.107854_bb0630","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/jsm.12464","article-title":"Death by testosterone? We think not!","volume":"11","author":"Traish","year":"2014","journal-title":"J. Sex. Med."},{"issue":"2","key":"10.1016\/j.maturitas.2023.107854_bb0635","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3109\/13685538.2014.913413","article-title":"Testosterone and cardiovascular risk: world\u2019s experts take unprecedented action to correct misinformation","volume":"17","author":"Morgentaler","year":"2014","journal-title":"Aging Male"},{"issue":"1","key":"10.1016\/j.maturitas.2023.107854_bb0640","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1210\/jc.2007-1792","article-title":"Low serum testosterone and mortality in older men","volume":"93","author":"Laughlin","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.maturitas.2023.107854_bb0645","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1210\/jc.2008-2650","article-title":"Low serum testosterone and estradiol predict mortality in elderly men","volume":"94","author":"Tivesten","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.maturitas.2023.107854_bb0650","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1177\/1060028014539918","article-title":"Risk of myocardial infarction in older men receiving testosterone therapy","volume":"48","author":"Baillargeon","year":"2014","journal-title":"Ann. Pharmacother."},{"issue":"8","key":"10.1016\/j.maturitas.2023.107854_bb0655","article-title":"Testosterone replacement therapy in hypogonadal men and myocardial infarction risk: systematic review & meta-analysis","volume":"13","author":"Lee","year":"2021","journal-title":"Cureus."},{"issue":"3","key":"10.1016\/j.maturitas.2023.107854_bb0660","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/bju.14536","article-title":"Long-term testosterone therapy in type 2 diabetes is associated with reduced mortality without improvement in conventional cardiovascular risk factors","volume":"123","author":"Hackett","year":"2019","journal-title":"BJU Int."},{"issue":"6","key":"10.1016\/j.maturitas.2023.107854_bb0665","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1001\/jama.2015.8881","article-title":"Effects of testosterone administration for 3 years on subclinical atherosclerosis progression in older men with low or low-normal testosterone levels: a randomized clinical trial","volume":"314","author":"Basaria","year":"2015","journal-title":"JAMA."},{"issue":"7","key":"10.1016\/j.maturitas.2023.107854_bb0670","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1001\/jama.2016.21043","article-title":"Testosterone treatment and coronary artery plaque volume in older men with low testosterone","volume":"317","author":"Budoff","year":"2017","journal-title":"JAMA."},{"issue":"2","key":"10.1016\/j.maturitas.2023.107854_bb0675","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1210\/jc.2017-02243","article-title":"The effect of testosterone on cardiovascular biomarkers in the testosterone trials","volume":"103","author":"Mohler","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.maturitas.2023.107854_bb0680","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1517\/14740338.2014.950653","article-title":"Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis","volume":"13","author":"Corona","year":"2014","journal-title":"Expert Opin. Drug Saf."},{"issue":"3","key":"10.1016\/j.maturitas.2023.107854_bb0685","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.amjmed.2016.09.017","article-title":"Cardiovascular risks of exogenous testosterone use among men: a systematic review and meta-analysis","volume":"130","author":"Alexander","year":"2017","journal-title":"Am. J. Med."},{"issue":"3","key":"10.1016\/j.maturitas.2023.107854_bb0690","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/cen.13084","article-title":"Testosterone therapy, association with age, initiation and mode of therapy with cardiovascular events: a systematic review","volume":"85","author":"Albert","year":"2016","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.maturitas.2023.107854_bb0695","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.thromres.2020.12.029","article-title":"Testosterone replacement therapy and the risk of venous thromboembolism: a systematic review and meta-analysis of randomized controlled trials","volume":"199","author":"Ayele","year":"2021","journal-title":"Thromb. Res."},{"issue":"8","key":"10.1016\/j.maturitas.2023.107854_bb0700","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.mayocp.2015.05.012","article-title":"Risk of venous thromboembolism in men receiving testosterone therapy","volume":"90","author":"Baillargeon","year":"2015","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.maturitas.2023.107854_bb0705","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.thromres.2018.10.023","article-title":"Testosterone therapy and venous thromboembolism: a systematic review and meta-analysis","volume":"172","author":"Houghton","year":"2018","journal-title":"Thromb. Res."},{"issue":"4","key":"10.1016\/j.maturitas.2023.107854_bb0710","first-page":"232","article-title":"Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate","volume":"22","author":"Huggins","year":"1972","journal-title":"CA Cancer J. Clin."},{"issue":"8","key":"10.1016\/j.maturitas.2023.107854_bb0715","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.urolonc.2020.04.008","article-title":"Testosterone replacement therapy (TRT) and prostate cancer: an updated systematic review with a focus on previous or active localized prostate cancer","volume":"38","author":"Lenfant","year":"2020","journal-title":"Urol. Oncol."},{"issue":"5","key":"10.1016\/j.maturitas.2023.107854_bb0720","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/bju.13417","article-title":"Endogenous and exogenous testosterone and the risk of prostate cancer and increased prostate-specific antigen (PSA) level: a meta-analysis","volume":"118","author":"Boyle","year":"2016","journal-title":"BJU Int."},{"issue":"5","key":"10.1016\/j.maturitas.2023.107854_bb0725","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0090-4295(00)01116-X","article-title":"Are serum hormones associated with the risk of prostate cancer? Prospective results from the Massachusetts Male Aging Study","volume":"57","author":"Mohr","year":"2001","journal-title":"Urology."},{"issue":"11 Pt B","key":"10.1016\/j.maturitas.2023.107854_bb0730","first-page":"E541","article-title":"Low testosterone levels are related to poor prognosis factors in men with prostate cancer prior to treatment","volume":"110","author":"Garcia-Cruz","year":"2012","journal-title":"BJU Int."},{"issue":"2","key":"10.1016\/j.maturitas.2023.107854_bb0735","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.eururo.2008.09.024","article-title":"Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth","volume":"55","author":"Morgentaler","year":"2009","journal-title":"Eur. Urol."},{"key":"10.1016\/j.maturitas.2023.107854_bb0740","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.urology.2018.07.064","article-title":"Testosterone therapy for high-risk prostate cancer survivors: a systematic review and meta-analysis","volume":"126","author":"Teeling","year":"2019","journal-title":"Urology."},{"issue":"10","key":"10.1016\/j.maturitas.2023.107854_bb0745","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.urolonc.2019.06.007","article-title":"Oncological safety of testosterone replacement therapy in prostate cancer survivors after definitive local therapy: a systematic literature review and meta-analysis","volume":"37","author":"Kardoust Parizi","year":"2019","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.maturitas.2023.107854_bb0750","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.urology.2015.11.006","article-title":"The relationship between testosterone-replacement therapy and lower urinary tract symptoms: a systematic review","volume":"88","author":"Kathrins","year":"2016","journal-title":"Urology."},{"issue":"6","key":"10.1016\/j.maturitas.2023.107854_bb0755","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.eururo.2016.01.043","article-title":"Effects of testosterone replacement therapy on lower urinary tract symptoms: a systematic review and meta-analysis","volume":"69","author":"Kohn","year":"2016","journal-title":"Eur. Urol."},{"issue":"7","key":"10.1016\/j.maturitas.2023.107854_bb0760","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s40618-022-01776-9","article-title":"Testosterone does not affect lower urinary tract symptoms while improving markers of prostatitis in men with benign prostatic hyperplasia: a randomized clinical trial","volume":"45","author":"Rastrelli","year":"2022","journal-title":"J. Endocrinol. Investig."},{"issue":"1","key":"10.1016\/j.maturitas.2023.107854_bb0765","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/cen.12936","article-title":"Effects of intermission and resumption of long-term testosterone replacement therapy on body weight and metabolic parameters in hypogonadal in middle-aged and elderly men","volume":"84","author":"Yassin","year":"2016","journal-title":"Clin. Endocrinol."},{"issue":"4","key":"10.1016\/j.maturitas.2023.107854_bb0770","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/17512433.2018.1445969","article-title":"Pharmacological management of late-onset hypogonadism","volume":"11","author":"Rastrelli","year":"2018","journal-title":"Expert. Rev. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.maturitas.2023.107854_bb0775","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/sm2.76","article-title":"Comparison of the effects of testosterone gels, injections, and pellets on serum hormones, erythrocytosis, lipids, and prostate-specific antigen","volume":"3","author":"Pastuszak","year":"2015","journal-title":"Sex Med."},{"issue":"2","key":"10.1016\/j.maturitas.2023.107854_bb0780","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/cen.14633","article-title":"Society for Endocrinology guidelines for testosterone replacement therapy in male hypogonadism","volume":"96","author":"Jayasena","year":"2022","journal-title":"Clin. Endocrinol."},{"issue":"9","key":"10.1016\/j.maturitas.2023.107854_bb0785","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1210\/JC.2015-1542","article-title":"Serum testosterone (T) level variability in T gel-treated older hypogonadal men: treatment monitoring implications","volume":"100","author":"Swerdloff","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.maturitas.2023.107854_bb0790","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/andr.12137","article-title":"Natesto, a novel testosterone nasal gel, normalizes androgen levels in hypogonadal men","volume":"4","author":"Rogol","year":"2016","journal-title":"Andrology."},{"issue":"6","key":"10.1016\/j.maturitas.2023.107854_bb0795","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1530\/EJE-12-0955","article-title":"Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis","volume":"168","author":"Corona","year":"2013","journal-title":"Eur. J. Endocrinol."},{"issue":"5","key":"10.1016\/j.maturitas.2023.107854_bb0800","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1210\/jc.2011-2513","article-title":"Characteristics of androgen deficiency in late-onset hypogonadism: results from the European Male Aging Study (EMAS)","volume":"97","author":"Tajar","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.maturitas.2023.107854_bb0805","doi-asserted-by":"crossref","first-page":"256","DOI":"10.5534\/wjmh.190061","article-title":"Treatment of functional hypogonadism besides pharmacological substitution","volume":"38","author":"Corona","year":"2020","journal-title":"World J0 Mens Health"},{"issue":"3","key":"10.1016\/j.maturitas.2023.107854_bb0810","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/ijo.2016.242","article-title":"Symptomatic response to testosterone treatment in dieting obese men with low testosterone levels in a randomized, placebo-controlled clinical trial","volume":"41","author":"Ng Tang Fui","year":"2017","journal-title":"Int. J. Obes."},{"issue":"4","key":"10.1016\/j.maturitas.2023.107854_bb0815","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.biopsych.2016.06.009","article-title":"Exogenous testosterone rapidly increases aggressive behavior in dominant and impulsive men","volume":"82","author":"Carre","year":"2017","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.maturitas.2023.107854_bb0820","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1530\/EJE-11-0221","article-title":"Onset of effects of testosterone treatment and time span until maximum effects are achieved","volume":"165","author":"Saad","year":"2011","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"10.1016\/j.maturitas.2023.107854_bb0825","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.sxmr.2017.04.001","article-title":"Erythrocytosis following testosterone therapy","volume":"6","author":"Ohlander","year":"2018","journal-title":"Sex Med. Rev."},{"issue":"10","key":"10.1016\/j.maturitas.2023.107854_bb0830","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1359\/jbmr.090818","article-title":"Clinical value of monitoring BMD in patients treated with bisphosphonates for osteoporosis","volume":"24","author":"Watts","year":"2009","journal-title":"J. Bone Miner. Res."}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512223004607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512223004607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:23:22Z","timestamp":1759915402000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512223004607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":165,"alternative-id":["S0378512223004607"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2023.107854","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EMAS position statement: Testosterone replacement therapy in older men","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2023.107854","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107854"}}